Lipid CME
EXPERT VIDEOCURBSIDE CONSULTSCME

Reducing Risk Through Non-LDL-C Avenues

Author(s)/Faculty: Michael Miller, MD, FACC, FAHA; Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI
Release Date: 11/29/2016Expiration Date: 11/27/2018
Credit Type: CMENumber of Credits: 0.25
Content Type: VideoProvider:
While statins are the treatment of choice for lowering LDL-C, many patients retain a high CV risk. This residual risk may in part be attributable to high triglyceride levels. In this educational activity, expert faculty will discuss elevated triglycerides and residual risk and evidence-based approaches to management.